Dr. Montserrat C Anguera's lab at the University of Pennsylvania focuses on understanding why females are more prone to developing systemic lupus erythematosus, an autoimmune disease. The lab studies how the X-chromosome, which carries many immunity-related genes, behaves differently in female B cells, particularly under chronic inflammation conditions. By examining gene regulation processes and epigenetic changes, they aim to reveal new insights into disease mechanisms and potential therapeutic targets for lupus.

Dr. Melanie Carless's lab focuses on understanding epilepsy by studying baboons, which have similar genetic and anatomical features to humans. The lab aims to develop better treatments for epilepsy by creating in vitro models using stem cells from baboons. This innovative research could lead to breakthroughs in how we approach epilepsy in humans, particularly for forms that are difficult to treat with current medications.

Dr. Alita Burmeister's lab at the University of Wisconsin Milwaukee focuses on understanding how bacteria evolve resistance to treatments, particularly using bacteriophages as an alternative to antibiotics. The lab studies the costs and benefits of different resistance mechanisms, such as mucoidy, which can both protect bacteria from phage attacks and affect their virulence. This research not only aims to find ways to use phages effectively in treating bacterial infections but also provides valuable hands-on research experience for undergraduates.

Dr. Vladimir Badovinac's lab at the University of Iowa focuses on understanding how radiation exposure affects the immune system, particularly memory CD8 T cells that are crucial for fighting infections. The lab aims to uncover the mechanisms behind radiation-induced immune dysfunction and identify strategies to improve the function and numbers of these important immune cells after exposure. Their research could lead to better medical countermeasures for individuals exposed to radiation, whether accidentally or intentionally.

Dr. Sunil S. Badve's lab at Emory University focuses on innovative approaches to improve the prediction and treatment of triple negative breast cancer (TNBC). By utilizing advanced technologies like artificial intelligence and deep learning, the lab aims to develop a comprehensive risk assessment tool known as the CaPRI score, which will help identify patients at high risk of lethal outcomes and optimize their therapy accordingly.

Eric H Baehrecke's lab at the University of Massachusetts Medical School studies the process of autophagy, which is how cells recycle and dispose of cellular waste. The research focuses on understanding how autophagy is regulated during the development of the fruit fly (Drosophila), providing insights that could help us understand similar processes in humans and how they are linked to diseases like cancer and neurodegeneration. By studying autophagy in specific cell types in the intestines, the lab aims to uncover how different cellular components are selected for degradation, which could lead to new therapeutic strategies for human health.

Dr. Linda Barlow's lab focuses on understanding how chemotherapy affects taste perception, especially regarding the cancer treatment drugs used for kidney cancer. The research explores how these drugs disrupt the regeneration of taste bud cells, particularly those responsible for sweet taste. The ultimate goal is to find ways to mitigate taste dysfunction in cancer patients, improving their quality of life during treatment.

Dr. Sydney Shaffer's lab at the University of Pennsylvania studies Barrett's esophagus, a condition that can lead to esophageal cancer. They focus on understanding how this condition progresses from non-dysplastic to dysplastic stages, which is crucial for developing better diagnostic tools and therapies. By using advanced techniques like single-cell analysis and 3D organoid models, their research aims to uncover the molecular changes that occur during this progression and identify potential targets for intervention.

Dr. Jonathan T.C. Liu's lab at Stanford University focuses on improving the diagnosis and risk assessment for Barrett's esophagus, a condition linked to esophageal cancer. They are developing advanced computational techniques for 3D pathology to provide better insights from biopsies, which can significantly enhance patient treatment decisions. By leveraging machine learning and 3D imaging, the lab aims to make the diagnosis process more accurate and reliable for pathologists.

Dr. Yuri Persidsky's lab focuses on how substances like alcohol and electronic cigarettes can damage the blood-brain barrier and lung functions. They study what happens at the cellular level during this damage and explore potential therapeutic interventions. Their work is crucial for understanding the long-term effects of these substances, particularly in adolescents, who are significant users of e-cigarettes.

Dr. Aryn Hilary Gittis' lab at Carnegie-Mellon University focuses on understanding and restoring brain function in diseases like Parkinson's Disease. They employ advanced techniques to target specific neurons in a brain region called the basal ganglia, exploring how these interventions can alleviate both motor and non-motor symptoms associated with the disease. The research aims to develop innovative therapies that not only treat symptoms but also promote long-term recovery of brain function.

Dr. Sujit Basu's research lab at Ohio State University focuses on advancing cancer treatment through immunotherapy. They specifically study the blockade of the CD200R pathway, which affects immune cell behaviors in the tumor environment. By understanding how to manipulate immune responses, Dr. Basu's team aims to improve the effectiveness of cancer therapies, potentially enhancing the way we treat various malignancies.

Kristian Michael Forbes' lab focuses on understanding how bats behave and shed viruses, which may impact the risk of these viruses spilling over to humans and domestic animals. By studying bat populations in Kenya and Belize, the lab aims to uncover the interactions between bat behavior, ecology, and viral dynamics to inform public health strategies. Their work is crucial in preventing the emergence of infectious diseases like COVID-19 from bat populations.

Dr. Andrew J. Beel's lab at Stanford University focuses on understanding the structure and function of the mitotic chromosome, particularly its central scaffold, which is crucial for proper genetic information dissemination during cell division. The research aims to elucidate the molecular composition and 3D architecture of this scaffold and to develop chemical modulators that could impact cancer cell behavior through scaffold manipulation. This work not only provides fundamental insights into chromosome biology but also has potential implications for cancer therapy.

Dr. Thomas J. Begley's lab at SUNY Albany focuses on understanding how genetic and environmental factors interact to influence cellular responses to toxic substances, particularly naphthalene found in wood smoke. They explore how modifications to RNA and DNA impact gene expression and responses to cell stress. By using techniques in molecular biology and animal models, the lab aims to uncover novel strategies to reduce the harmful effects of air pollutants on human health.

Dr. Michael Czech's lab focuses on understanding how certain fat cells, called beige adipocytes, can improve metabolic health in conditions like obesity and diabetes. They use advanced CRISPR technology to convert regular fat cells into beige adipocytes, which can help in weight loss and improve body metabolism. The lab's research aims to discover the underlying mechanisms that allow these fat cells to help the body utilize energy better and combat fat accumulation in the liver.

Dr. William A. Beltran’s lab focuses on understanding and treating inherited retinal diseases, which can cause blindness. They work primarily with canine models that mimic these human diseases, helping to unravel the genetic and molecular basis of conditions like retinitis pigmentosa. By developing new therapies based on their findings, they aim to improve the quality of life for patients with these previously untreatable conditions.

Dr. Jennifer A Benanti's lab studies how cells grow and divide, focusing specifically on the cell cycle, which is crucial for normal development and cancer prevention. By investigating molecular mechanisms, particularly the role of phosphorylation, her research aims to uncover how cells respond to stress and how mutations can contribute to diseases like cancer. Overall, her work seeks to find new strategies for controlling cellular proliferation and improving therapeutic approaches in oncology.

The lab of Dr. Andres Bendesky at Columbia University focuses on understanding the biological mechanisms that influence parental behavior, particularly in relation to the neurosteroid allopregnanediol. By studying different species of mice, the research aims to uncover how hormones affect the motivation for parental care, which is crucial for healthy child development. The lab's work has implications for understanding postpartum depression and child neglect.

Dr. Eric Bennett's lab at UC San Diego focuses on understanding how cells maintain the quality of their proteins, which is critical for health and can impact conditions such as aging and neurodegenerative diseases. They explore the cellular mechanisms that control the production and degradation of proteins, particularly focusing on the role of ubiquitin ligases, which help tag defective proteins for destruction. The goal is to develop strategies that enhance cellular quality control systems to combat diseases linked to protein misfolding and toxicity.